Alpha Crest Capital Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$83.14 - $145.99 $241,272 - $423,662	-2,902 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$110.08 - $142.92 $319,452 - $414,753	2,902 New	2,902 $344,000
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $306,830 - $431,176	-3,104 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $204,181 - $325,982	3,104 New	3,104 $301,000
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $285,431 - $408,746	-4,455 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $282,729 - $426,852	-4,345 Reduced 49.38%	4,455 $382,000
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $312,912 - $413,135	5,300 Added 151.43%	8,800 $572,000
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $101,535 - $259,805	3,500 New	3,500 $256,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.24B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.